Evidence map›Paper›PMID 40008377›Full record

ArticleMedComm2025

SIRT1 Alleviates Mitochondrial Fission and Necroptosis in Cerebral Ischemia/Reperfusion Injury via SIRT1-RIP1 Signaling Pathway.

Xuan Wei, Hanjing Guo, Guangshan Huang, Haoyue Luo, Lipeng Gong, Pan Meng, Jiyong Liu, Wenli Zhang, Zhigang Mei

Abstract read
In one paragraph

Article in MedComm, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xuan WeiKey Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases College of Integrated Traditional Chinese and Western Medicine Hunan University of Chinese Medicine Changsha Hunan China.
Hanjing GuoKey Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases College of Integrated Traditional Chinese and Western Medicine Hunan University of Chinese Medicine Changsha Hunan China.
Guangshan HuangKey Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases College of Integrated Traditional Chinese and Western Medicine Hunan University of Chinese Medicine Changsha Hunan China.
Haoyue LuoKey Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases College of Integrated Traditional Chinese and Western Medicine Hunan University of Chinese Medicine Changsha Hunan China.
Lipeng GongKey Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases College of Integrated Traditional Chinese and Western Medicine Hunan University of Chinese Medicine Changsha Hunan China.
Pan MengKey Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases College of Integrated Traditional Chinese and Western Medicine Hunan University of Chinese Medicine Changsha Hunan China.
Jiyong LiuHunan Provincial Key Laboratory of Traditional Chinese Medicine Diagnostics Hunan University of Chinese Medicine Changsha Hunan China.
Wenli ZhangSchool of Pharmacy Hunan University of Chinese Medicine Changsha Hunan China.
Zhigang MeiKey Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases College of Integrated Traditional Chinese and Western Medicine Hunan University of Chinese Medicine Changsha Hunan China.ORCID https://orcid.org/0000-0002-9099-7099

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Programmed cell death, including necroptosis, plays a critical role in the pathogenesis of cerebral ischemia/reperfusion injury (CIRI). Silent information regulator 1 (SIRT1) has been identified as a potential therapeutic target for CIRI, yet its precise role in regulating necroptosis remains controversial. Furthermore, the potential interaction between SIRT1 and receptor-interacting protein kinase 1 (RIP1) in this context is not fully understood.

Indexed as

cerebral ischemia/reperfusion injuryDRP1mitochondrial fissionnecroptosisRIP1SIRT1

Identifiers

PMID40008377
PMCPMC11850763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.